Quantcast

Global Blood Glucose Monitoring Devices Industry

September 24, 2013

Reportbuyer.com just published a new market research report: Global Blood Glucose Monitoring Devices Industry

London (PRWEB) September 24, 2013

This report analyzes the worldwide markets for Blood Glucose Monitoring Devices in US$ Million by the following Product Segments: Blood Glucose Strips, Blood Glucose Meters, and Lancets.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World.

Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets.

The report profiles 94 companies including many key and niche players such as Abbott Diabetes Care, Inc., Arkray, Inc., Arkray USA, Inc., Bayer Healthcare, Bionime Corp., B. Braun Melsungen AG, DexCom Inc., LifeScan Inc. Medtronic, Nipro Diagnostics, Inc., Nova Biomedical Corporation, Roche Diagnostics Corp., and Terumo Europe NV.

Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations I-1

Disclaimers I-2

Data Interpretation & Reporting Level I-2

Quantitative Techniques & Analytics I-3

Product Definitions and Scope of Study I-3

Blood Glucose Strips I-3

Blood Glucose Meters I-3

Lancets I-4

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW II-1

A Prelude II-1

Table 1: Worldwide Prevalence of Diabetes Mellitus by

Region: 2012 & 2030 (includes corresponding Graph/Chart) II-1

Growth Stimulants in a Nutshell II-3

Competitive Landscape II-3

Table 2: Leading Players in the World Blood Glucose Meters

Market (2012): Market Share Breakdown for Roche, LifeScan,

Bayer, Abbott and Others (includes corresponding

Graph/Chart) II-4

Recession in Retrospect and the Road Ahead II-4

2. MARKET TRENDS, ISSUES AND DRIVERS II-6

Increasing Prevalence of Diabetes Buoyed by Burgeoning Ageing

Populace II-6

Table 3: Global Population Statistics for the 65+ Age Group:

2012 II-6

Targeted Screening of Ageing Population Vital to Stem

Diabetes Epidemic II-7

Rising Awareness and Need for Testing Propels Market Growth II-7

Pre-Diabetes Testing II-8

Post-Prandial Glucose Level Monitoring II-8

Online Marketing Increases Market Competition II-8

Government Efforts to Curb Healthcare Expenditure on Diabetes

Care II-9

Self-Monitoring of Blood Glucose (SMBG) Remains a Viable Option II-9

Rising Significance of Remote Blood Glucose Monitoring II-10

Rising Incidence and Undiagnosed Population in Developing

Countries Offer Significant Growth Opportunities II-10

China: An Untapped Goldmine for Blood Glucose Monitoring

Devices II-11

Diabetic Epidemic Spurs Indian Market for Blood Glucose

Monitoring II-11

After PDAs, SMBG Makers Turn to Mobile Devices to Woo Users

On the Move II-12

Mobile Phone Penetration: An Opportunity Indicator for

Mobile-Based BGM Devices II-12

Table 4: Top Ten Countries by Number of Mobile Users (2012)

(includes corresponding Graph/Chart) II-13

Technological Innovations in the Blood Glucose Monitoring

Market: Spearheading Growth II-14

Artificial Pancreas Technology: A Potential Game Changer for

BGM Market II-15

Demand for Convenience Drives Development of Non-Invasive

BGM Devices II-16

Research & Development Initiatives in Non-Invasive Glucose

Monitors II-17

Select Ocular Glucose Monitors under Development II-18

Diasensor 1000: The World’s First Non-Invasive Glucose Sensor II-18

Ultrasound Device Under Development to Monitor Glucose Levels II-18

Real World Challenges Facing Non-Invasive & Painless BGM II-18

Manufacturers Step up Focus on Multi-Featured Blood Glucose

Monitors II-19

CGM Technology: The New Torch-bearer for the BGM Devices Market II-19

Continuous Glucose Monitor (CGM) Vs Conventional Blood

Glucose Monitor (BGM) II-20

Medtronics Dominates the Global CGM Devices Market II-21

Challenges Faced by the CGMS Market II-22

3. DIABETES – A MACRO PERSPECTIVE II-23

Diabetes in Adults: A Leading Killer in Developed and

Developing Nations II-23

Diabetes in Children and Young People II-23

What is Diabetes? II-23

Types of Diabetes II-24

Type I Diabetes: Insulin-Dependent Diabetes Mellitus (IDDM) II-24

Type II Diabetes: Non-Insulin Dependent Diabetes Mellitus

(NIDDM) II-25

NIDDM: Higher Risk of Cardiovascular Disease II-25

Gestational Diabetes II-26

Impaired Fasting Glycaemia (IFG) & Impaired Glucose

Tolerance (IGT) II-26

Table 5: Prevalence of Diabetes Mellitus in North America

(2012 & 2030): Breakdown by Country and Age Group (In 000

People & %) (includes corresponding Graph/Chart) II-26

Table 6: Prevalence of Diabetes Mellitus in Europe (2012 &

2030): Breakdown by Country and Age Group (In 000 People &

%) II-27

Table 7: Prevalence of Diabetes Mellitus in South East

Asia (2012 & 2030): Breakdown by Country and Age Group (In

000 People & %) (includes corresponding Graph/Chart) II-28

Table 8: Prevalence of Diabetes Mellitus in Western Asia,

Pacific Regions (2012 & 2030): Breakdown by Country and Age

Group (In 000 People & %) II-29

Table 9: Prevalence of Diabetes Mellitus in South &

Central America (2012 & 2030): Breakdown by Country and

Age Group (In 000 People & %) II-30

Table 10: Prevalence of Diabetes Mellitus in Africa (2012 &

2030): Breakdown by Country and Age Group (In 000 People & %)

(includes corresponding Graph/Chart) II-31

Table 11: Prevalence of Diabetes Mellitus in Middle East &

North Africa (2012 & 2030): Breakdown by Country and Age

Group (In 000 People & %) II-32

4. PRODUCT OVERVIEW II-33

Blood Glucose Monitoring II-33

Blood Glucose Monitoring Devices II-33

Blood Glucose Meters II-34

Blood Glucose Monitoring Meters: A Historical Perspective II-34

Types of Blood Glucose Meters II-34

All-In-One Blood Glucose Meters II-34

Combined Wrist Blood Pressure and Blood Glucose Meters II-34

Wrist-Watch Glucose Meters II-35

BGMs with In-Built Food Monitoring Feature II-35

Continuous Blood Glucose Meters II-35

Talking Blood Glucose Meters II-35

Painless Blood Glucose Meters II-36

Multisite Blood Glucose Meters II-36

Plasma Blood Glucose Meters II-36

Measurement Units II-36

A Review of Select Blood Glucose Meters in the Market II-36

A Review of Select Invasive Blood Glucose Meters II-38

Various Continuous Blood Glucose Monitoring Devices:

Product Details & Status II-38

Blood Glucose Strips II-40

Lancets II-40

5. PRODUCT INNOVATIONS/INTRODUCTIONS II-41

Omron Unveils Advanced Blood Glucose Monitors II-41

ARKRAY USA Announces Compatibility of GLUCOCARD® Blood

Glucose Meters with Glooko Mobile App II-41

Bayer HealthCare Pharmaceuticals Unveils XT Glucometer and

NEXT Test strips under CONTOUR® Brand II-41

GE Healthcare and Bionime Introduce GE100 Blood Glucose

Monitoring System II-42

Nova Biomedical Unveils Nova Max™ Blood Glucose Monitoring

System II-42

BEURER Launches Three-in-one Blood Glucose Monitor II-42

Bayer Diabetes Care to Launch Glucometer II-42

Cambridge Consultants Design Eco-friendly Blood Glucose Monitor II-42

ARKRAY Unveils Audio-Enabled Blood Glucose Monitoring System II-43

Sanofi Introduces iBGStar iPhone Blood Glucose Meter in

Various Countries II-43

Abbott Introduces FreeStyle InsuLinx in Canada II-43

Eidia to Introduce LIFE CHECK II-44

Telcare Displays Cellular Blood Glucose Meter at AADE II-44

Sanofi Introduces BGSTAR® and IBGSTAR® Blood Glucose Meters

in France and Germany II-44

LifeScan Introduces ONETOUCH® SelectSimple™ II-45

Telcare Integrates Blood Glucose Monitoring with Wireless

Connectivity II-45

Sensa Core Introduces Gluco Spark Advanced Glucose Monitoring

System II-45

Bayer Launches DIDGET™ Blood Glucose Meter for Diabetic Children II-46

Abbott Diabetes Care Introduces Precision Xtra™ Biosensor

Blood Glucose Test Strip II-46

Infopia America Introduces SmartDiabetes Product Range II-46

Fujitsu Launches Mobile Phone Service for Diabetic Patients II-47

ACON Introduces On Call® Resolve Blood Glucose Monitoring System II-47

QuickMedical® Releases New BGM System II-47

Horizon MedCorp Offers New Resupply Program II-48

Nova Biomedical Provides Wireless Solution for Glucose and

Creatinine Meters II-48

Roche Diagnostic Introduces Accu-Chek(R) Glucose Monitoring

Device II-48

Qualcomm and Telcare to Introduce Mobile Health Monitoring

Device II-49

Artificial Life Rolls Out GluCoMO II-49

LifeScan Introduces OneTouch Delica Lancing System II-49

Pepex™ Releases Multi-Functional Blood Glucose Meter II-49

Mendor to Unveil Discreet Meter II-50

ARKRAY Releases the Assure® Blood Glucose Monitoring System II-50

Arkray Launches Ark Care™ System II-50

Medtronic Introduces CareLink® Pro 3.0 Therapy Management

Software for Diabetes II-51

Abbott Launches FreeStyle Lite® Test Strips for Blood Glucose

in Australian Market II-51

LifeScan to Introduce One Touch® Verio™ Glucose Monitor II-51

Medtronic to Unveil iPro2 Professional CGM II-52

Nokia Unveils MyGlucoHealth Diabetes Software II-52

Bayer Launches Blood Glucose Meter: CONTOUR® USB II-52

LifeScan Introduces One Touch “Verio” Glucose Monitor II-52

Biocon Introduces Breeze-2 Blood Glucose Meters II-53

We Carewell Biotech Launches Eukare Bio-Sensored Glucometer II-53

6. RECENT INDUSTRY ACTIVITY II-54

Abbott Recalls FreeStyle InsuLinx® BGMS II-54

LifeScan Initiates Recall and Replacement of OneTouch® Verio

®IQ BGMs II-54

Lifescan Obtains FDA Approval for OneTouch VerioSync II-54

Telcare BGM® Receives Clearance to Operate on Verizon Network II-55

GE Healthcare Signs Licensing Agreement with Bionime II-55

Modz Inks Agreement with Novo Nordisk II-56

Merck Serono Inks Distribution Deal with Mendor II-56

Abbott Renews Non-Exclusive Agreement with INSULET II-56

Pepex Biomedical Inks Manufacturing Agreement with Tech Group II-56

Pharmaco Bags Exclusive Distribution Rights for CareSens

Blood Glucose Meters II-57

Roche Obtains FDA Approval for ACCU-CHEK Inform II System II-57

Dexcom Obtains USFDA Approval and CE Mark for Dexcom G4™

PLATINUM CGMS II-58

Abbott Obtains FDA Approval for FreeStyle InsuLinx BGM System II-58

StatStrip™ Glucose Monitor from Nova Receives FDA Approval

for Neonatal Testing II-58

Philosys Obtains CE Mark for its Gmate® SMART BGMS II-59

Roche Obtains FDA Approval for Accu-Chek Combo System II-59

ConnectedHealth Inks Agreements with Nonin Medical, Entra and

A&D Medical II-59

ARKRAY USA Secures Continuum of Care Contract from Premier II-60

Entra Health Obtains Approval from TPD for MyGlucoHealth

Wireless Meter II-60

LifeScan Terminates Supply Agreement with Medtronic MiniMed II-60

Telcare Obtains FDA 510(k) Clearance for 3G BGM II-60

SANOFI Obtains FDA 510(k) Clearance for Its iBGSTAR™ BGMS II-61

Bayer Receives FDA Approval for Contour Next EZ II-61

Medtronic Obtains FDA Approval for iPro®2 CGM II-61

Medtronic Commences Investigational Device Exemption Study of

Enlite™ Sensor II-62

Medtronic Partners with Ford to Develop Automotive Glucose

Monitor II-62

Animas and LifeScan Co-Develop Wireless Insulin Pump II-62

Abbott Receives CE Mark for New Blood Glucose Monitoring System II-63

Insulet Takes Over Neighborhood Diabetes II-63

Perrigo and AgaMatrix Ink Exclusive Distribution and Sales Deal II-63

Biosign Technologies Revises Agreement with DynamiCARE II-64

KarmelSonix and OMRON Healthcare Enter into Distribution Deal II-64

Freescale Semiconductor Enters into an Exclusive Partnership

with Cactus Semiconductor II-64

Accu-Chek® Enters into an Alliance with Novo Nordisk II-65

Bayer HealthCare and Medtronic Expand Partnership II-65

PositiveID Announces Partnership with HMD BioMedical to

Produce iGlucometer II-65

Japanese Branch of Sanofi-Aventis to Sell AgaMatrix's Blood

Glucose Meters II-65

Zyxel and Entra Health Systems Ink Agreement II-66

Panasonic to Manufacture Blood Sugar Meters at New Facility II-66

Roche Diabetes and ICW to Co-develop Diabetes Management System II-66

Animas Obtains Approval for Feature Enhancement on OneTouch®

Ping® II-67

PTPA Approves Bionime's Blood-Glucose Meters II-67

Bayer Inks Strategic Partnership with Biocon II-67

Novation Confers Agreement to Roche Diagnostics II-67

Nipro Corporation Acquires Home Diagnostics II-68

AgaMatrix Enters into Agreement with Sanofi-Aventis II-68

AmbiCom Holdings Bags WL54-CF Wi-Fi Card Purchase Order II-68

Abbot Obtains FDA 510(k) Clearance for FreeStyle® Test Strips II-68

7. FOCUS ON SELECT GLOBAL PLAYERS II-69

Abbott Diabetes Care, Inc. (US) II-69

Arkray, Inc. (Japan) II-69

Arkray USA, Inc. (US) II-69

Bayer Healthcare (US) II-70

Bionime Corp. (Taiwan) II-70

B. Braun Melsungen AG (Germany) II-71

DexCom, Inc. (US) II-71

LifeScan, Inc. (US) II-71

Medtronic (US) II-72

Nipro Diagnostics, Inc. (US) II-72

Nova Biomedical Corporation (USA) II-73

Roche Diagnostics Corp. (US) II-73

Terumo Europe NV (Belgium) II-74

8. GLOBAL MARKET PERSPECTIVE II-75

Table 12: World Recent Past, Current & Future Analysis for

Blood Glucose Monitoring Devices by Geographic Region – US,

Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin

America and Rest of World Markets Independently Analyzed

with Annual Revenue Figures in US$ Million for Years 2010

through 2018 (includes corresponding Graph/Chart) II-75

Table 13: World Historic Review for Blood Glucose Monitoring

Devices by Geographic Region – US, Canada, Japan, Europe,

Asia-Pacific (excluding Japan), Latin America And Rest of

World Markets Independently Analyzed with Annual Revenue

Figures in US$ Million for Years 2004 through 2009 (includes

corresponding Graph/Chart) II-76

Table 14: World 15-Year Perspective for Blood Glucose

Monitoring Devices by Geographic Region – Percentage Breakdown

of Revenue in Dollars for US, Canada, Japan, Europe,

Asia-Pacific (excluding Japan), Latin America and Rest of

World Markets for Years 2004, 2013 & 2018 (includes

corresponding Graph/Chart) II-77

Table 15: World Recent Past, Current & Future Analysis for

Blood Glucose Strips by Geographic Region – US, Canada,

Japan, Europe, Asia-Pacific (excluding Japan), Latin America

and Rest of World Markets Independently Analyzed with Annual

Revenue Figures in US$ Million for Years 2010 through 2018

(includes corresponding Graph/Chart) II-78

Table 16: World Historic Review for Blood Glucose Strips by

Geographic Region – US, Canada, Japan, Europe, Asia-Pacific

(excluding Japan), Latin America and Rest of World Markets

Independently Analyzed with Annual Revenue Figures in US$

Million for Years 2004 through 2009 (includes corresponding

Graph/Chart) II-79

Table 17: World 15-Year Perspective for Blood Glucose Strips

by Geographic Region – Percentage Breakdown of Revenue in

Dollars for US, Canada, Japan, Europe, Asia-Pacific

(excluding Japan), Latin America and Rest of World Markets

for Years 2004, 2013 & 2018 (includes corresponding

Graph/Chart) II-80

Table 18: World Recent Past, Current & Future Analysis for

Blood Glucose Meters by Geographic Region – US, Canada,

Japan, Europe, Asia-Pacific (excluding Japan), Latin America

and Rest of World Markets Independently Analyzed with Annual

Revenue Figures in US$ Million for Years 2010 through 2018

(includes corresponding Graph/Chart) II-81

Table 19: World Historic Review for Blood Glucose Meters by

Geographic Region – US, Canada, Japan, Europe, Asia-Pacific

(excluding Japan), Latin America and Rest of World Markets

Independently Analyzed with Annual Revenue Figures in US$

Million for Years 2004 through 2009 (includes corresponding

Graph/Chart) II-82

Table 20: World 15-Year Perspective for Blood Glucose Meters

by Geographic Region – Percentage Breakdown of Revenue in

Dollars for US, Canada, Japan, Europe, Asia-Pacific

(excluding Japan), Latin America and Rest of World Markets

for Years 2004, 2013 & 2018 (includes corresponding

Graph/Chart) II-83

Table 21: World Recent Past, Current & Future Analysis for

Lancets by Geographic Region – US, Canada, Japan, Europe,

Asia-Pacific (excluding Japan), Latin America and Rest of

World Markets Independently Analyzed with Annual Revenue

Figures in US$ Million for Years 2010 through 2018 (includes

corresponding Graph/Chart) II-84

Table 22: World Historic Review for Lancets by Geographic

Region – US, Canada, Japan, Europe, Asia-Pacific (excluding

Japan), Latin America and Rest of World Markets Independently

Analyzed with Annual Revenue Figures in US$ Million for

Years 2004 through 2009 (includes corresponding Graph/Chart) II-85

Table 23: World 15-Year Perspective for Lancets by Geographic

Region – Percentage Breakdown of Revenue in Dollars for US,

Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin

America and Rest of World Markets for Years 2004, 2013 & 2018

(includes corresponding Graph/Chart) II-86

III. MARKET

1. THE UNITED STATES III-1

A.Market Analysis III-1

Current and Future Analysis III-1

Table 24: Prevalence of Diabetes Mellitus in North America

by Country: 2012 III-1

Table 25: North America Incidence of Type 1 Diabetes in

Children: 2012 (includes corresponding Graph/Chart) III-2

Diabetes in America: Key Facts and Figures III-2

Self-Monitoring Meters and Strips Sales Dip But Remain

Buoyant Amid Recession III-3

Market Growth Propellants III-4

Technologic Innovations Fuel US SMBG Market III-5

Accuracy: A Major Cause of Concern Plaguing SMBG Systems III-5

Emerging Technologies Threaten Conventional Products III-5

TGC Protocols: A Key Driver for Point of Care BGM Market III-6

Manufacturers Under Pressure to Discount BGM Product Prices III-6

Table 26: North American Blood Glucose Strips Market

(2012): Percentage Share Breakdown of Dollar Sales of SMBG

Glucose Strips and POC Glucose Strips (includes

corresponding Graph/Chart) III-6

Drugstores Clearly Benefiting from the Diabetic Care Category III-7

Competitive Landscape III-7

Table 27: US Market for Glucose Test Kits (2012):

Percentage Breakdown of Value Sales by Top Brands

(includes corresponding Graph/Chart) III-8

Challenges Facing Market Participants III-8

Snapshot of Leading BGM Meters in the United States III-9

Strategic Corporate Developments III-14

Product Launches III-20

Select Major Players III-22

B.Market Analytics III-26

Table 28: US Recent Past, Current & Future Analysis for

Blood Glucose Monitoring Devices by Product Segment – Blood

Glucose Strips, Blood Glucose Meters and Lancets Markets

Independently Analyzed with Annual Revenue Figures in US$

Million for Years 2010 through 2018 (includes corresponding

Graph/Chart) III-26

Table 29: US Historic Review for Blood Glucose Monitoring

Devices by Product Segment – Blood Glucose Strips, Blood

Glucose Meters and Lancets Markets Independently Analyzed

with Annual Revenue Figures in US$ Million for Years 2004

through 2009 (includes corresponding Graph/Chart) III-27

Table 30: US 15-Year Perspective for Blood Glucose

Monitoring Devices by Product Segment – Percentage Breakdown

of Revenue in Dollars for Blood Glucose Strips, Blood

Glucose Meters and Lancets Markets for Years 2004, 2013 &

2018 (includes corresponding Graph/Chart) III-28

2. CANADA III-29

A.Market Analysis III-29

Current and Future Analysis III-29

Strategic Corporate Developments III-29

Product Launches III-30

B.Market Analytics III-31

Table 31: Canadian Recent Past, Current & Future Analysis

for Blood Glucose Monitoring Devices by Product Segment -

Blood Glucose Strips, Blood Glucose Meters and Lancets

Markets Independently Analyzed with Annual Revenue Figures

in US$ Million for Years 2010 through 2018 (includes

corresponding Graph/Chart) III-31

Table 32: Canadian Historic Review for Blood Glucose

Monitoring Devices by Product Segment – Blood Glucose

Strips, Blood Glucose Meters and Lancets Markets

Independently Analyzed with Annual Revenue Figures in US$

Million for Years 2004 through 2009 (includes corresponding

Graph/Chart) III-32

Table 33: Canadian 15-Year Perspective for Blood Glucose

Monitoring Devices by Product Segment – Percentage

Breakdown of Revenue in Dollars for Blood Glucose Strips,

Blood Glucose Meters and Lancets Markets for Years 2004,

2013 & 2018 (includes corresponding Graph/Chart) III-33

3. JAPAN III-34

A.Market Analysis III-34

Current and Future Analysis III-34

Japanese Medical Device Industry: A Macro Perspective III-34

Product Launch III-35

Arkray, Inc. – A Key Player III-35

B.Market Analytics III-36

Table 34: Japanese Recent Past, Current & Future Analysis

for Blood Glucose Monitoring Devices by Product Segment -

Blood Glucose Strips, Blood Glucose Meters and Lancets

Markets Independently Analyzed with Annual Revenue Figures

in US$ Million for Years 2010 through 2018 (includes

corresponding Graph/Chart) III-36

Table 35: Japanese Historic Review for Blood Glucose

Monitoring Devices by Product Segment – Blood Glucose

Strips, Blood Glucose Meters and Lancets Markets

Independently Analyzed with Annual Revenue Figures in US$

Million for Years 2004 through 2009 (includes corresponding

Graph/Chart) III-37

Table 36: Japanese 15-Year Perspective for Blood Glucose

Monitoring Devices by Product Segment – Percentage Breakdown

of Revenue in Dollars for Blood Glucose Strips, Blood

Glucose Meters and Lancets Markets for Years 2004, 2013 &

2018 (includes corresponding Graph/Chart) III-38

4. EUROPE III-39

A.Market Analysis III-39

Current and Future Scenario III-39

Prevalence of Diabetes: Aging Population in Dominion III-39

Table 37: Prevalence of Diabetes Mellitus in Europe: 2012 III-40

Obesity: A Major Cause of Diabetes III-41

Diabetes Care in Europe: Riddled with Challenges III-41

St Vincent Declaration – A Step in the Right Direction III-42

B.Market Analytics III-43

Table 38: European Recent Past, Current & Future Analysis

for Blood Glucose Monitoring Devices by Geographic Region -

France, Germany, UK, Italy, Spain, Russia and Rest of

Europe Markets Independently Analyzed with Annual Revenue

Figures in US$ Million for Years 2010 through 2018

(includes corresponding Graph/Chart) III-43

Table 39: European Historic Review for Blood Glucose

Monitoring Devices by Geographic Region – France, Germany,

UK, Italy, Spain, Russia and Rest of Europe Markets

Independently Analyzed with Annual Revenue Figures in US$

Million for Years 2004 through 2009 (includes corresponding

Graph/Chart) III-44

Table 40: European 15-Year Perspective for Blood Glucose

Monitoring Devices by Geographic Region – Percentage

Breakdown of Revenue in Dollars for France, Germany, UK,

Italy, Spain, Russia and Rest of Europe Markets for Years

2004, 2013 & 2018 (includes corresponding Graph/Chart) III-45

Table 41: European Recent Past, Current & Future Analysis

for Blood Glucose Monitoring Devices by Product Segment -

Blood Glucose Strips, Blood Glucose Meters and Lancets

Markets Independently Analyzed with Annual Revenue Figures

in US$ Million for Years 2010 through 2018 (incl

Read the full report:

Global Blood Glucose Monitoring Devices Industry

http://www.reportbuyer.com/pharma_healthcare/diagnostics/global_blood_glucose_monitoring_devices_industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

For more information:

Sarah Smith

Research Advisor at Reportbuyer.com

Email: query@reportbuyer.com

Tel: +44 208 816 85 48

Website: http://www.reportbuyer.com

For the original version on PRWeb visit: http://www.prweb.com/releases/2013/9/prweb11156338.htm


Source: prweb



comments powered by Disqus